Skip to content
sellNotable cluster of 2

Heng Fai Ambrose Chan sold $1.1M of IBO

director, owner at IMPACT BIOMEDICAL INC.. 1,689,693 shares at an average of $0.66, traded Apr 2, 2025, filed Apr 4, 2025.

Warning score
68
Value
$1.1M
1,689,693 shares
Holdings after
0
-198% from before
From 52-week low
+8%
low $6.71, close $7.22
From 52-week high
-89%
high $62.78, as of Apr 2, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $1.1M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    2 insiders selling within 14 days
    +8

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

IBOOct 9, 2026 · close 4.25
Since filing Apr 4, 2025: -65.1%SPY +56.6% · excess -121.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001641172-25-002819, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 2, 2025SOpen-market sale
Common stockindirect: See footnote
-300,000$0.58$174k553,904Apr 4, 2025
Apr 2, 2025SOpen-market sale
Common stockindirect: See footnote
-200,000$0.67$135k353,904Apr 4, 2025
Apr 2, 2025SOpen-market sale
Common stockindirect: See footnote
-2,349$0.67$1,581351,555Apr 4, 2025
Apr 2, 2025SOpen-market sale
Common stockindirect: See footnote
-382,427$0.58$223k351,631Apr 4, 2025
Apr 3, 2025SOpen-market sale
Common stockindirect: See footnote
-351,631$0.58$204k0Apr 4, 2025
Apr 3, 2025SOpen-market sale
Common stockindirect: See footnote
-273,286$0.78$213k180,000Apr 4, 2025
Apr 4, 2025SOpen-market sale
Common stockindirect: See footnote
-180,000$0.96$173k0Apr 4, 2025

Related signals

Other insiders at IMPACT BIOMEDICAL INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
12Weak
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$1,686
906 shares
-0%
41Moderate
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$88k
161,000 shares
-100%
54Moderate
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director
$174k
351,555 shares
-100%
63Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$845k
890,800 shares
-85%
68Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Heng Fai Ambrose Chan
director, owner
$2.9M
2,526,918 shares
-163%
65Notable
IBOsell 2
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$2.0M
605,620 shares
-364%
2Weak
IBObuy
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$310
200 shares
+0%
45Moderate
IBOsell
IMPACT BIOMEDICAL INC.
Dss, Inc.
owner
$249k
53,300 shares
-100%
25Weak
IBObuy
IMPACT BIOMEDICAL INC.
Frank D Heuszel
Chief Executive Officer
$1,129
500 shares
+1%
25Weak
IBObuy
IMPACT BIOMEDICAL INC.
Frank D Heuszel
Chief Executive Officer
$2,739
1,050 shares
+1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Heng Fai Ambrose Chan sold $1.1M of IBO | InsiderTell